These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8156351)

  • 1. Improved sensitivity of colour Doppler flow imaging of colorectal hepatic metastases using galactose microparticles: a preliminary report.
    Leen E; Angerson WJ; Warren HW; O'Gorman P; Moule B; Carter EC; McArdle CS
    Br J Surg; 1994 Feb; 81(2):252-4. PubMed ID: 8156351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
    Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N
    J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possibility of differentiating small hyperechoic liver tumours using contrast-enhanced colour Doppler ultrasonography: a preliminary study.
    Tano S; Ueno N; Tomiyama T; Kimura K
    Clin Radiol; 1997 Jan; 52(1):41-5. PubMed ID: 9022579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound imaging of flow patterns in liver metastases from colorectal cancer.
    Rafaelsen SR; Solvig J
    Scand J Gastroenterol; 2004 Aug; 39(8):761-5. PubMed ID: 15513362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Color Doppler imaging of liver metastases. The value phase-III of a US contrast agent: SH U 508 A (Levovist) Schering.
    Campani R; Bozzini A; Calliada F; Bottinelli O; Anguissola R; Conti MP; Corsi G
    Radiol Med; 1994 May; 87(5 Suppl 1):32-40. PubMed ID: 8209016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility study of an ultrasound contrast agent (levovist) in color Doppler imaging of liver neoplasms.
    Jiang Y; Dai Q; Liu J; Zhang J; Chang X; Cai S; Tan L
    Chin Med Sci J; 1999 Sep; 14(3):167-9. PubMed ID: 12903818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound contrast agent Levovist in colour Doppler sonography of hepatocellular carcinoma in Chinese patients.
    Khong PL; Chau MT; Fan ST; Leong LL
    Australas Radiol; 1999 May; 43(2):156-9. PubMed ID: 10901894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions.
    Furuse J; Nagase M; Ishii H; Yoshino M
    Br J Radiol; 2003 Jun; 76(906):385-92. PubMed ID: 12814924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced color flows in hepatic tumors.
    Yang CC; Chen CH; Yeh YH
    Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early experience in the use of Levovist ultrasound contrast in the evaluation of liver masses.
    Plew J; Sanki J; Young N; Gruenewald S; Dwyer R; Brancatisano R
    Australas Radiol; 2000 Feb; 44(1):28-31. PubMed ID: 10761256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Color Doppler sonography in liver surgery. Status of perioperative monitoring].
    Bunk A; Stoelben E; Konopke R; Nagel M; Saeger HD
    Ultraschall Med; 1998 Oct; 19(5):202-12. PubMed ID: 9842683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of SH U 508 A (Levovist) in color Doppler ultrasonography of hepatocellular carcinoma vascularization.
    Angeli E; Carpanelli R; Crespi G; Zanello A; Sironi S; Del Maschio A
    Radiol Med; 1994 May; 87(5 Suppl 1):24-31. PubMed ID: 8209014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Native and signal-enhanced power Doppler sonography for characterization of liver lesions].
    Strunk H; Stuckmann G; Fröhlich E; Textor J; Wilhelm K; Hortling N; Remig J
    Rofo; 1998 Apr; 168(4):344-51. PubMed ID: 9589096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
    Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
    AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of duplex/colour Doppler sonography in hepatic arterial chemotherapy for patients with liver metastases from colorectal carcinoma.
    Guadagni S; Pizzutilli A; Mancini E; Varrone A; Palumbo G; Amicucci G; Perri S; Deraco M; Fiorentini G
    Eur J Surg Oncol; 2000 Jun; 26(4):381-6. PubMed ID: 10873360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantification of hepatic arterial and portal venous flow using ultrasound contrast agents for early detection of liver metastases of colorectal cancers].
    Kissel A; Rixe O; Methlin A; Nabet M; Tranquart F; Rubini B; Jafaar S; Gaucher H
    J Radiol; 2001 Nov; 82(11):1621-5. PubMed ID: 11894547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vascularization patterns in focal liver lesions: comparison of plain and signal-enhanced amplitude-modulated color duplex ultrasonography].
    Hosten N; Steger W; Bechstein WO; Zendel WJ; Venz S; Lemke AJ; Weber S; Vogl TJ; Felix R
    Rofo; 1997 Jun; 166(6):507-13. PubMed ID: 9273003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatic focal lesions: role of color Doppler ultrasonography with contrast media].
    Pennisi F; Farina R; Politi G; Lombardo R; Puleo S
    Radiol Med; 1998 Dec; 96(6):579-87. PubMed ID: 10189920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
    Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
    Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures.
    Cedrone A; Pompili M; Sallustio G; Lorenzelli GP; Gasbarrini G; Rapaccini GL
    Am J Gastroenterol; 2001 Jun; 96(6):1854-9. PubMed ID: 11419839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.